Abstract:Graphical and Lay Summary NADPH‐dependent oxidoreductases are important catalysts for production of chiral compounds, but insufficient supply of expensive nicotinamide cofactors have prevented their widespread exploitation. In this study, the authors developed a metabolic engineering strategy and a multienzyme modulation strategy for a NADPH‐dependent glufosinate dehydrogenases (GluDH) whole‐cell biocatalytic system to enhance intracellular NADP+ pool and catalytic efficiency. The cofactor self‐sufficient whole‐cell biocatalystic system was successfully applied for the asymmetric synthesis of L‐phosphinothricin, afformed a super high space‐time yield without the need to add exogenous cofactors. The engineering strategy might serve as a useful approach for constructing a cofactor self‐sufficient system of other oxidoreductases. NAD(P)H‐dependent oxidoreductases are crucial biocatalysts for synthesizing chiral compounds. Yet, the industrial implementation of enzymatic redox reactions is often hampered by an insufficient supply of expensive nicotinamide cofactors. Here, a cofactor self‐sufficient whole‐cell biocatalyst was developed for the enzymatic asymmetric reduction of 2‐oxo‐4‐[(hydroxy)(‐methyl)phosphinyl] butyric acid (PPO) to L‐phosphinothricin (L‐PPT). The endogenous NADP+ pool was significantly enhanced by regulating Preiss‐Handler pathway toward NAD(H) synthesis and, in the meantime, introducing NAD kinase to phosphorylate NAD(H) toward NADP+. The intracellular NADP(H) concentration displayed a 2.97‐fold increase with the strategy compared with the wild‐type strain. Furthermore, a recombinant multi‐enzyme cascade biocatalytic system was constructed based on the Escherichia coli chassis. In order to balance multi‐enzyme co‐expression levels, the strategy of modulating rate‐limiting enzyme PmGluDH by RBS strengths regulation successfully increased the catalytic efficiency of PPO conversion. Finally, the cofactor self‐sufficient whole‐cell biocatalyst effectively converted 300 mM PPO to L‐PPT in 2 h without the need to add exogenous cofactors, resulting in a 2.3‐fold increase in PPO conversion (%) from 43% to 100%, with a high space‐time yield of 706.2 g L−1 d−1 and 99.9% ee. Overall, this work demonstrates a technological example for constructing a cofactor self‐sufficient system for NADPH‐dependent redox biocatalysis.

A circuitous route for in vitro multi-enzyme cascade production of cytidine triphosphate to overcome the thermodynamic bottleneck

Efficient One-Pot Synthesis of Cytidine 5'-Monophosphate Using an Extremophilic Enzyme Cascade System.

A Cocktail of Protein Engineering Strategies: Breaking the Enzyme Bottleneck One by One for High UTP Production in Vitro.

Biocatalytic Asymmetric Synthesis of L-Phosphinothricin Using a One-Pot Three Enzyme System and a Continuous Substrate Fed-Batch Strategy

Iterative Conformational Dynamics-Guided Protein Engineering Reshapes Biocatalyst Properties for Efficient and Cost-Effective Cytidine 5ʹ-Monophosphate Production

Engineered Cytidine Triphosphate Synthetase with Reduced Product Inhibition.

Multistep construction of metabolically engineered Escherichia coli for enhanced cytidine biosynthesis

Development of a multi-enzyme cascade for 2'3'-cGAMP synthesis from nucleosides

Engineering substrate and energy metabolism for living cell production of cytidine-5-diphosphocholine

Efficient multi-enzyme-catalyzed CDP-choline production driven by an ATP donor module

Modularized Reconstruction of Pyrimidine Pathway in Escherichia Coli for Enhanced Pyrimidine Nucleosides Biosynthesis

Enhanced Cytidine Production by a Recombinant Escherichia Coli Strain Using Genetic Manipulation Strategies

Enhancement of Cytidine Production by Coexpression of Gnd, Zwf, and Prs Genes in Recombinant Escherichia Coli Cyt15

One-Pot Two-Stage Biocatalytic Cascade to Produce l-Phosphinothricin by Two Enantioselective Complementary Aminotransferases at High Substrate Loading via a Deracemization Process

Design of a cofactor self‐sufficient whole‐cell biocatalyst for enzymatic asymmetric reduction via engineered metabolic pathways and multi‐enzyme cascade

Deoxycytidine production by a metabolically engineered Escherichia coli strain

High-level living cell production of cytidine-5′-diphosphocholine in metabolically engineered yeast

High Production of Glutathione by in Vitro Enzymatic Cascade after Thermostability Enhancement

Enzymatic Synthesis of 2′-Deoxyuridine by Whole Cell Catalyst Co-Expressing Uridine Phosphorylase and Thymidine Phosphorylase Through Auto-Induction System

Improving the level of the cytidine biosynthesis in E. coli through atmospheric room temperature plasma mutagenesis and metabolic engineering

Rapid Prototyping Enzyme Homologs to Improve Titer of Nicotinamide Mononucleotide Using a Strategy Combining Cell‐free Protein Synthesis with Split GFP